Clinical Features, Management, and Recurrence of Acute Ischemic Stroke Occurring in Patients on Oral Anticoagulant Treatment for Nonvalvular Atrial Fibrillation: A Real-World Retrospective Study.

Autor:	Grifoni E; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Pagni B; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Sansone T; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Baldini M; Neurology, San Giuseppe Hospital, Empoli, Italy., Bertini E; Neurology, San Giuseppe Hospital, Empoli, Italy., Giannoni S; Neurology, San Giuseppe Hospital, Empoli, Italy., Di Donato I; Neurology, San Giuseppe Hospital, Empoli, Italy., Sivieri I; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Iandoli G; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Mannini M; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Giglio E; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Vescera V; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Brai E; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Signorini I; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Cosentino E; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Micheletti I; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Cioni E; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Pelagalli G; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Dei A; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Giordano A; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Dainelli F; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Romagnoli M; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Mattaliano C; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Schipani E; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Murgida GS; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Di Martino S; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Francolini V; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy., Masotti L; Internal Medicine II and Stroke Unit, San Giuseppe Hospital, Empoli, Italy.
Jazyk:	angličtina
Zdroj:	The neurologist [Neurologist] 2024 Nov 01; Vol. 29 (6), pp. 329-338. Date of Electronic Publication: 2024 Nov 01.
DOI:	10.1097/NRL.0000000000000579
Abstrakt:	Objectives: The optimal management of acute ischemic stroke (AIS) in patients with oral anticoagulation (OA) is challenging. Our study aimed to analyze the clinical characteristics and outcome of AIS in patients with OA for nonvalvular atrial fibrillation (NVAF). Methods: We retrospectively analyzed data on NVAF patients with AIS on direct oral anticoagulants (DOAC) or vitamin K antagonists (VKA) admitted to our Stroke Unit from 2017 to 2022. Ninety-day modified Rankin Scale (mRS), 90-day, and 12-month stroke recurrences were recorded. Results: A total of 169 patients (53.2% female, mean age 82.8±6.7 y), 117 (69.2%) on DOAC, and 52 on VKA (30.8%), were enrolled. Mean age, in-hospital mortality, and 90-day mRS ≥4 were significantly higher in VKA patients. 63.4% of VKA patients had subtherapeutic INR, whereas 47.1% of DOAC patients were on low-dose (14.2% off-label). Large vessel occlusion and embolic etiology were more frequent in VKA patients (34.6% vs. 26.4%, P =0.358; 92.3% vs. 74.3%, P =0.007, respectively), whereas lacunar strokes were more frequent in DOAC patients (19.8% vs. 12.2%, P =0.366). Among patients on VKA before AIS 86.4% were switched to DOAC, whereas a DOAC-to-VKA and a DOAC-to-DOAC switch were done in 25.4% and 11.7%, respectively. Stroke recurrence occurred in 6.4% of patients at 90 days and 10.7% at 12 months. Anticoagulant switching was not associated with stroke recurrences. Conclusions: In our study, nonembolic etiology was more frequent in DOAC patients and anticoagulant switching did not reduce the risk of stroke recurrence. Prospective multicentric studies are warranted. Competing Interests: The authors declare no conflict of interest. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu